UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040105
Receipt number R000045694
Scientific Title Effect to BMI by the helth program supporting intake of dietary fiber
Date of disclosure of the study information 2020/06/15
Last modified on 2022/04/12 08:13:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect to BMI by the helth program supporting intake of dietary fiber

Acronym

Effect to BMI by the helth program supporting intake of dietary fiber

Scientific Title

Effect to BMI by the helth program supporting intake of dietary fiber

Scientific Title:Acronym

Effect to BMI by the helth program supporting intake of dietary fiber

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect to BMI by the helth program supporting intake of dietary fiber

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

BMI before and 4-8-12weeks after intake, 4 weeks after the end of intake

Key secondary outcomes

blood test, blood pressure,physical activity, food intake, defecation frequency, defecation quantity,body weight, body-fat percentage before and 4-8-12weeks after intake, 4 weeks after the end of intake


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake dietary fiber-rich food once a day for 12 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese males and females aged 20 to 60 years old
2) Subjects who can perform informed consent
3) Subjects who can connect to the specific application and come to the clinic to perform tests under the schedule
4) Subjects who can fill down their daily food intake, body weight and blood pressure to the specific application
4) Subjects who can measure their body weight and blood pressure everyday using the supplied scale
6) Subjects who can cook and intake the test food at least 5 times a week
4) Subjects with HbA1c(NGSP) 5.2 to 6.4 %
8) Subjects with BMI 25 to 30

Key exclusion criteria

1) Subjects who are taking medical treatments
2) Subjects who have severe medical history of mental/sleep/liver/kidny/heart/lung nad /or blood disease
3) Subjects who have severe medical history of digestive disease
4) Subjects who have performed blood donation over 200mL in the past 1 month or over 400 ml in the past 3 months
5) Subjects who have experienced bad mood or poor physical condition due to blood sampling in the past
6) Subjects who can be allergic to test food
7) Heavy drinkers (Average amount of pure alcohol per day 60 g or more).
8) Subjects who will chage their life style (e.g. long-term trip)
9) Subjects who are pregnant, breast-feeding or have possibility (hope) of pregnancy.
10) Subjects who participated in other clinical studies in the past 3 months.
11) Subjects who/whose families are engaged in development, manufacture or sell of health food or cosmetics

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Koikeda

Organization

Shiba Palace Clinic

Division name

Chair

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Public contact

Name of contact person

1st name Ko
Middle name
Last name Masuda

Organization

SOUKEN Co., Ltd

Division name

Management Division

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1555

Homepage URL


Email

k_masuda@mail.souken-r.com


Sponsor or person

Institute

Shiba Palace Clinic

Institute

Department

Personal name



Funding Source

Organization

Welby Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 15 Day


Related information

URL releasing protocol

Unpublished

Publication of results

Unpublished


Result

URL related to results and publications

Unpublished

Number of participants that the trial has enrolled

59

Results

Unpublished

Results date posted

2022 Year 04 Month 12 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Unpublished

Participant flow

Unpublished

Adverse events

Unpublished

Outcome measures

Unpublished

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 03 Month 26 Day

Date of IRB

2020 Year 03 Month 26 Day

Anticipated trial start date

2020 Year 06 Month 15 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 08 Day

Last modified on

2022 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045694


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name